John D. Parker

John D. Parker

Auto-generated profile, based on publicly available information

John D. Parker

Division of Cardiology, Mount Sinai Hospital, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1999 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
DSDon D. Sin
Don D. Sin
FFFabia Fitzgerald
Fabia Fitzgerald
JPJohn D. Parker
John D. Parker
GNGary Newton
Gary Newton
JFJohn S. Floras
John S. Floras
TBT. Douglas Bradley
T. Douglas Bradley
In previous analyses of the occurrence of central (CSA) and obstructive sleep apnea (OSA) in patients with congestive heart failure (CHF), only men were studied and risk factors for these disorders were not well characterized. We therefore analyzed risk factors for CSA and OSA in 450 consecutive patients with CHF (382 male, 68 female) referred to our sleep laboratory. Risk factors for CSA were male gender (odds ratio [OR] 3.50; 95% confidence interval [CI], 1.39 to 8.84), atrial fibrillation (OR 4.13; 95% CI 1.53 to 11.14), age > 60 yr (OR 2.37; 95% CI 1.35 to 4.15), and hypocapnia (Pco2< 38 mm Hg during wakefulness) (OR 4.33; 95% CI 2.50 to 7.52). Risk factors for OSA differed by gender: in men, only body mass index (BMI) was significantly associated with OSA (OR for a BMI > 35 kg/m2, 6.10; 95% CI 2.86 to 13.00); whereas, in women, age was the only important risk factor (OR for age > 60 yr, 6.04; 95% CI 1.75 to 20.0). We conclude that historical information, supplemented by a few simple laboratory tests may enable physicians to risk stratify CHF patients for the presence of CSA or OSA, and the need for diagnostic polysomnography for such patients. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure.

1 April 2007 in JACC
Verified
Journal Article
Closed access
HWHanqiao Wang
Hanqiao Wang
JPJohn D. Parker
John D. Parker
GNGary E. Newton
Gary E. Newton
JFJohn S. Floras
John S. Floras
SMSusanna Mak
Susanna Mak
TBT. Douglas Bradley
T. Douglas Bradley

1 September 2004 in The Lancet
Verified
Journal Article
Closed access
PPPhilip A Poole-Wilson
Philip A Poole-Wilson
JLJacobus Lubsen
Jacobus Lubsen
BKBridget-Anne Kirwan
Bridget-Anne Kirwan
FDFred J van Dalen
Fred J van Dalen
GWGilbert Wagener
Gilbert Wagener
SWSimon Weber
Simon Weber

18 September 2006 in Archives of internal medicine (1960)
Verified
Journal Article
Closed access
PDF file
MAMichael Arzt
Michael Arzt
TYTerry Young
Terry Young
LFLaurel Finn
Laurel Finn
JSJames B. Skatrud
James B. Skatrud
CRClodagh Mai Ryan
Clodagh Mai Ryan
TBT. Douglas Bradley
T. Douglas Bradley
Research from JAMA Internal Medicine — Sleepiness and Sleep in Patients With Both Systolic Heart Failure and Obstructive Sleep Apnea

12 September 2006 in Circulation
Verified
Journal Article
Closed access
PDF file
MGMihai Gheorghiade
Mihai Gheorghiade
GSGeorge Sopko
George Sopko
LLLeonardo De Luca
Leonardo De Luca
EVEric J. Velazquez
Eric J. Velazquez
JPJohn D. Parker
John D. Parker
RBRobert O. Bonow
Robert O. Bonow

19 February 1998 in New England Journal of Medicine
Verified
Journal Article
Closed access
JPJohn D. Parker
John D. Parker
The organic nitrates are widely used in the management of coronary artery disease. They are given not only to patients with stable angina pectoris, but also to those with unstable angina, acute myocardial infarction, and heart failure. Although they are effective for the treatment of these disorders, their therapeutic value is compromised by the rapid development of tolerance during sustained therapy. This review will be limited to the use of organic nitrates in patients with chronic stable angina pectoris, but many of the principles enunciated are relevant to other clinical situations.In 1879 Murrell reported that a 1 percent solution . . .